We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
-11.62%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.03B
AUM Growth
-$132M
Cap. Flow
+$20.6M
Cap. Flow %
2.01%
Top 10 Hldgs %
29.82%
Holding
462
New
17
Increased
58
Reduced
119
Closed
62

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$11.1M
2
GEN icon
Gen Digital
GEN
+$9.34M
3
GRMN
Garmin
GRMN
+$9.3M
4
UNFI icon
United Natural Foods
UNFI
+$9.22M
5
AMGN icon
Amgen
AMGN
+$5.68M

Top Sells

Rank Stock Value
1
PFF icon
iShares Preferred and Income Securities ETF
PFF
+$8.97M
2
MA icon
Mastercard
MA
+$4.79M
3
GEM icon
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
+$4.72M
4
TMO icon
Thermo Fisher Scientific
TMO
+$3.8M
5
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$3.74M

Sector Composition

Rank Sector Weight
1 Healthcare 17.34%
2 Technology 16.69%
3 Industrials 11.06%
4 Financials 10.91%
5 Consumer Discretionary 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JMBS icon
26
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.7B
$18.6M 1.81%
388,504
-4,309
-1% -$208K
GSY icon
27
Invesco Ultra Short Duration ETF
GSY
$3.9B
$18.1M 1.77%
365,940
-14,066
-4% -$699K
PYPL icon
28
PayPal
PYPL
$49.3B
$16M 1.56%
229,347
+61,585
+37% +$5.34M
LDOS icon
29
Leidos
LDOS
$14.8B
$14.9M 1.45%
148,171
+2,693
+2% +$279K
GILD icon
30
Gilead Sciences
GILD
$160B
$14.7M 1.43%
237,130
+4,387
+2% +$272K
VRP icon
31
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$14.1M 1.37%
635,551
-71,677
-10% -$1.67M
TPYP icon
32
Tortoise North American Pipeline ETF
TPYP
$869M
$14.1M 1.37%
580,263
-8,962
-2% -$236K
APTV icon
33
Aptiv
APTV
$11.9B
$13.1M 1.28%
147,324
+3,227
+2% +$329K
INTC icon
34
Intel
INTC
$456B
$13M 1.26%
346,368
+6,243
+2% +$270K
UTHR icon
35
United Therapeutics
UTHR
$25.6B
$12.9M 1.26%
+54,788
New +$11.1M
NOC icon
36
Northrop Grumman
NOC
$77.5B
$12.8M 1.25%
26,802
+408
+2% +$187K
LHX icon
37
L3Harris
LHX
$51.3B
$11.1M 1.08%
45,953
+1,070
+2% +$258K
LOW icon
38
Lowe's Companies
LOW
$117B
$11.1M 1.08%
63,403
+1,270
+2% +$245K
GEM icon
39
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.67B
$11M 1.07%
368,954
-149,624
-29% -$4.72M
WMT icon
40
Walmart Inc
WMT
$880B
$10.1M 0.99%
250,416
+5,124
+2% +$236K
BSJN
41
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
$9.92M 0.97%
432,574
-4,916
-1% -$117K
EEM icon
42
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$9.84M 0.96%
245,483
-89,259
-27% -$3.74M
FV icon
43
First Trust Dorsey Wright Focus 5 ETF
FV
$3.63B
$9.73M 0.95%
234,886
+12,944
+6% +$600K
GRMN
44
Garmin
GRMN
$58B
$8.83M 0.86%
89,894
+88,270
+5,435% +$9.3M
UNFI icon
45
United Natural Foods
UNFI
$2.96B
$8.65M 0.84%
+219,570
New +$9.22M
GEN icon
46
Gen Digital
GEN
$16.8B
$8.34M 0.81%
+379,770
New +$9.34M
BSJO
47
DELISTED
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
$8.17M 0.8%
374,754
-1,716
-0.5% -$39.2K
BIIB icon
48
Biogen
BIIB
$29.6B
$8.08M 0.79%
39,604
-1,740
-4% -$356K
JKHY icon
49
Jack Henry & Associates
JKHY
$11.1B
$7.4M 0.72%
41,131
-2,550
-6% -$478K
BDX icon
50
Becton Dickinson
BDX
$46.5B
$6.74M 0.66%
27,329
-3,183
-10% -$808K
1
2
3 4 5

Similar funds

PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM

Atwood & Palmer's Q2 2022 Portfolio in Review

As of Q2 2022, Atwood & Palmer held 462 positions worth $1.03B, down 11% from $1.16B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Atwood & Palmer's Q2 2022 filing shows 17 new, 58 increased, 119 reduced and 62 closed positions. Its largest new stake was United Therapeutics: 54,788 shares worth $12.9M. The largest sale was iShares Preferred and Income Securities ETF, an estimated $8.97M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Atwood & Palmer's largest Q2 2022 buy was United Therapeutics: 54,788 shares worth $12.9M.
  • Atwood & Palmer added most to Garmin in Q2 2022, an estimated $9.3M increase.
  • Atwood & Palmer's biggest Q2 2022 reduction was iShares Preferred and Income Securities ETF, cutting an estimated $8.97M.
  • Atwood & Palmer fully exited Cerner Corp in Q2 2022, selling an estimated $624K.
  • Atwood & Palmer's ten largest holdings make up 30% of its $1.03B portfolio in Q2 2022.
  • Atwood & Palmer opened 17 new positions and closed 62 in Q2 2022.
  • Atwood & Palmer's portfolio value fell 11% quarter-over-quarter to $1.03B.

Based on Atwood & Palmer's 13F filing for Q2 2022, filed 21 Jul 2022.